Rising Prevalence Of Cancer Fueling The Market Growth Due To Increasing Life Expectancy Is Supporting Development Across The Sotorasib Tablets Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Sotorasib Tablets Market By 2030 Based On Its 2026 Value?

The sotorasib tablets market has seen rapid expansion in recent years. It is projected to increase from $1.92 billion in 2025 to $2.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be attributed to several factors including a rise in the diagnosis of non-small cell lung cancer, advancements in kras mutation research, regulatory approvals for targeted oncology drugs, the expansion of molecular diagnostic capabilities, and an increase in oncology clinical trials.

The sotorasib tablets market is projected to experience swift expansion in the coming years, reaching $3.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth can be linked to several factors, including the increasing advancement of next-generation kras inhibitors, the rise of combination therapy strategies, the extension of targeted treatments to new cancer indications, the growing utilization of real-world evidence studies, and the increased embrace of oncology precision medicine. Key trends during this period are expected to involve the rising acceptance of kras g12c inhibitor therapies, a heightened focus on targeted lung cancer treatments, the increased use of oral oncology medications, the broadening of companion diagnostic testing, and improved monitoring of resistance mechanisms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28336&type=smp

What Primary Factors Are Fueling The Expansion Of The Sotorasib Tablets Market?

The escalating incidence of cancer is anticipated to fuel the expansion of the sotorasib tablets market in the coming years. Cancer is characterized by the uncontrolled proliferation of atypical cells, which can infiltrate tissues and metastasize to various body parts. The increasing occurrence of cancer is linked to an aging demographic, as advanced age represents the primary risk factor for developing most cancer types, with a majority of diagnoses found in individuals over 65 years old. Sotorasib tablets function by specifically and permanently targeting the KRAS G12C mutation, thereby deactivating the mutated protein to inhibit unregulated cell growth in patients with advanced solid tumors, notably non-small cell lung cancer. For example, in February 2024, the World Health Organization, an international organization based in Switzerland focused on global health policy and public health initiatives, projected more than 35 million new cancer cases in 2050, signifying a 77% increase from the estimated 20 million cases in 2022. Consequently, the rising prevalence of cancer is stimulating the growth of the sotorasib tablets market.

Which Segment-Based Categories Are Covered In The Sotorasib Tablets Market?

The sotorasib tablets market covered in this report is segmented –

1) By Dosage Form: 40 Milligrams (Mg) Tablets, 120 Milligrams (Mg) Tablets, 240 Milligrams (Mg) Tablets, Other Dosage Forms

2) By Patient Demographics: Adolescents, Adult, Senior Adults

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Non-Small Cell Lung Cancer, Colorectal Cancer, Other Applications

5) By End-User: Hospitals, Oncology Centers, Clinics, Other End-Users

Which Trends Are Expected To Shape The Sotorasib Tablets Market?

Leading firms in the sotorasib tablets market are prioritizing the creation of novel therapies, such as combination treatments, to enhance effectiveness and counteract resistance. These combination therapies involve the concurrent administration of two or more medications to combat cancer via multiple pathways, thereby boosting treatment efficacy, mitigating or postponing drug resistance, lowering the chance of cancer returning, and elevating patient outcomes and quality of life. As an example, in January 2025, Amgen Inc., a US-based biotechnology company, secured U.S. Food and Drug Administration (FDA) clearance for the combined use of sotorasib and panitumumab for adult patients suffering from KRAS G12C–mutated metastatic colorectal cancer (mCRC) who had undergone prior standard chemotherapy. The basis for this approval stemmed from the findings of the Phase 3 CodeBreaK 300 study, which showed that the combined treatment more than doubled progression-free survival when contrasted with the investigator’s chosen standard-of-care therapy, thus offering a crucial new alternative for individuals with this challenging cancer. Sotorasib functions as a pioneering oral KRAS G12C inhibitor, operating by specifically targeting and immobilizing the mutant KRAS protein in its dormant state, consequently impeding cancer cell proliferation and signaling pathways instigated by this mutation.

Who Are The Leading Firms Participating In The Sotorasib Tablets Market?

Major companies operating in the sotorasib tablets market are Amgen Inc.

Access The Complete Sotorasib Tablets Market Report:

https://www.thebusinessresearchcompany.com/report/sotorasib-tablets-global-market-report

Which Area Represents The Largest Portion Of The Sotorasib Tablets Market?

North America was the largest region in the sotorasib tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotorasib tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Sotorasib Tablets Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28336&type=smp

Browse Through More Reports Similar to the Global Sotorasib Tablets Market 2026, By The Business Research Company

Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Ashwagandha Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/ashwagandha-extract-global-market-report

Cholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795